Literature DB >> 7442801

Delayed formation of proteoglycan aggregate structures in human articular cartilage disease states.

T R Oegema.   

Abstract

Proteoglycans are major components of many extracellular matrices. In cartilage, they provide reversible resistance to compression and exist as molecules with molecular weights (MWs) of 1-3 x 10(6). There is a central protein core of MWs approximately 2 x 10(5) (refs 1, 2) with specialized subregions, one containing mainly the chondroitin sulphate chains, another most of the keratan sulphate chains, and a third is a largely globular structure interacting specifically with both hyaluronic acid and a link protein to form stable aggregate structures such as those identified in human articular cartilage. In embryonic and tissue culture systems, proteoglycans are isolated as aggregate structures in as little as 5--10 min after synthesis (sulphation) with no nonaggregating precursor detected. However, Heinegärd and Hascall have characterized the small proportion of nonaggregating proteoglycan present in bovine nasal septum cartilage and found that it contained more peptide than the aggregating proteoglycan. Work by Upholt et al. has suggested that the MW of unprocessed protein core, synthesized by a wheat-germ translating system from chick sternal cartilage mRNA, is approximately 340,000, leaving open the possibility of intermediates. I report here the presence, in some human cartilages, of a proteoglycan population that initially will not aggregate with the hyaluronic acid but subsequently can be chased into aggregate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442801     DOI: 10.1038/288583a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  10 in total

1.  Synthesis and extracellular assembly of proteoglycans in human articular cartilage.

Authors:  M T Bayliss
Journal:  Agents Actions       Date:  1988-02

Review 2.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

3.  Acquisition of hyaluronate-binding affinity in vivo by newly synthesized cartilage proteoglycans.

Authors:  J D Sandy; J R O'Neill; L C Ratzlaff
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

4.  Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage.

Authors:  Terri Wells; Catherine Davidson; Matthias Mörgelin; Joseph L E Bird; Michael T Bayliss; Jayesh Dudhia
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

5.  Structural and biochemical abnormalities of articular cartilage in rheumatoid arthritis.

Authors:  D R Mitrovic; N Darmon
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Effects of tissue compression on the hyaluronate-binding properties of newly synthesized proteoglycans in cartilage explants.

Authors:  R L Sah; A J Grodzinsky; A H Plaas; J D Sandy
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

7.  Differences in the rates of aggregation of proteoglycans from human articular cartilage and chondrosarcoma.

Authors:  M T Bayliss; G D Ridgway; S Y Ali
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

8.  Biosynthesis of proteoglycan in vitro by cartilage from human osteochondrophytic spurs.

Authors:  C J Malemud; V M Goldberg; R W Moskowitz; L L Getzy; R S Papay; D P Norby
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

9.  The affinity of newly synthesized proteoglycan for hyaluronic acid can be enhanced by exposure to mild alkali.

Authors:  A H Plaas; J D Sandy
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

10.  The role of aggrecan in normal and osteoarthritic cartilage.

Authors:  Peter J Roughley; John S Mort
Journal:  J Exp Orthop       Date:  2014-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.